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On-line mixed hemodiafiltration with a feedback for ultrafil-
tration control: Effect on middle-molecule removal.
Background. Increased middle-molecular uremic toxin re-
moval seems to favorably influence survival in dialysis patients.
The aim of this study was to verify if, in on-line mixed hemodia-
filtration, solute removal by convection may be enhanced by
forcing the ultrafiltration rate (QUF) and optimizing the infusion
technique in order to achieve the highest possible filtration
fraction (FF).
Methods. Removal of 2-microglobulin (2-m), urea, creati-
nine, and phosphate were compared in 20 patients randomly
submitted to one dialysis session (A), one postdilution hemodi-
afiltration session (B), and three sessions of mixed hemodiafil-
tration (C, D, and E) at different infusion rates (QS). In mixed
hemodiafiltration, a newly developed feedback system auto-
matically maintained the transmembrane pressure (TMP)
within its highest range of safety (250 to 300 mm Hg) at constant
QUF, while ensuring the maximum FF by splitting infusion be-
tween pre- and postdilution.
Results. A mean QS of 134  20 mL/min (mean FF  0.65)
was attained in post-HDF, and up to 307  41 mL/min (mean
FF  0.69) in mixed hemodiafiltration. The mean dialysate
clearances (KDQ) for all tested solutes and urea eKt/V were
significantly higher in all hemodiafiltration sessions than in
dialysis. Only in the case of urea did the infusion mode have
no significant effect. KDQ for 2-m was maximal in session D
and significantly higher than in session B (90.2  11 mL/min
vs. 77.5  11 mL/min; P  0.02). KDQ for 2-m significantly
correlated with QS and the plasma water flow rate (QPW). The
highest KDQ for 2-m was found at values of QS QPW. Beyond
this value KDQ decreased.
Conclusion. The mixed infusion mode in hemodiafiltration,
controlled by the TMP-ultrafiltration feedback, seems to im-
prove the efficiency of hemodiafiltration by fully exploiting
the convective mechanism of solute removal. The feedback
automatically adjusted the infusion rate and site to the maxi-
mum FF taking into account flow conditions, internal pressures,
and hydraulic permeability of the dialyzer and their complex
interactions.
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In the last decade several observational studies have
reported a reduced death risk in patients undergoing
hemodialysis with high-flux membranes [1–5]. In some
studies, such an effect has been associated with the in-
creased removal of middle-molecular uremic toxins pro-
moted by these membranes [3–5], independently from
the effects related to their high biocompatibility. On the
other hand, overall survival was not influenced signifi-
cantly by high-flux membranes in an Italian registry study
[6] and in the HEMO Study [7]. In the latter study,
however, a reduced rate of cardiac death in patients of
the high-flux group was reported, as well as longer sur-
vival in the subgroup undergoing hemodialysis for more
than 3.7 years. The relatively low mean 2-microglobulin
(2-m) clearance (K) in the high-flux group (34  11
mL/min) possibly prevented the achievement of a clearer
difference in the overall outcome between groups. In-
deed, solute transport obtained by “internal filtration”
in high-flux hemodialysis is definitely lower than that
attainable by convection in hemodiafiltration, provided
that high rates of fluid exchange are applied. A prospec-
tive randomized study comparing high-flux hemodialysis
with hemodiafiltration at a relatively low infusion vol-
ume (8 to 12 L/session) found similar basal 2-m levels
over a period of 24 months [8], but significant differences
in basal 2-m levels emerged from a long-term prospec-
tive study in which a mean filtration volume of 21 L
was applied [9]. Compared to high-flux hemodialysis, an
increase in convective removal was shown in hemodiafil-
tration for2-m [9–15], for asymmetric dimethyl-arginine
(ADMA) [16], for complement fractions, such as factor D
[9, 17], fraction Ba [17], C3a, C5a [18], and, with a vari-
able contribution of absorption, for proinflammatory
cytokines, such as tumor-necrosis factor- (TNF-) and
interleukin-1 (IL-1), IL-6, and IL-8 [19, 20]. These mid-
dle-molecular compounds have a pathogenic role or are
markers of the most frequent long-term complications
and causes of death in hemodialysis patients, such as
dialysis-related amyloidosis, cardiovascular disease, in-
flammation, and malnutrition. Thus, even in the absence
of definite evidence, there are strong indications to ad-
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vise the use of dialytic strategies, which can ensure in-
creased removal of middle-molecular uremic toxins [21].
Among these, hemodiafiltration is undoubtedly the fore-
most choice, provided that the high potential of hydraulic
and solute permeability of synthetic membranes is prop-
erly exploited. However, this is generally not the case in
clinical hemodiafiltration practice. During postdilution
hemodiafiltration, hemoconcentration, and high trans-
membrane pressure (TMP) can cause frequent clinical
and technical problems. As a precautionary measure,
low ultrafiltration rate (QUF) is often set, thus limiting
the efficiency of the technique. The predilution infusion
mode (prehemodiafiltration) partially prevents these
drawbacks, although at the expense of the cumulative
solute transfer as a consequence of the diluted solute
concentration available for diffusion and convection [10,
14, 22]. Recently, we demonstrated that the mixed pre-
and postdilution infusion mode (mixed hemodiafiltra-
tion) ensured safer rheological and operating conditions
by better preserving the characteristics of water and sol-
ute transport of the membrane, and achieved a removal
of small and large size solutes which was similar to post-
hemodiafiltration when QUF was matched for the two
infusion modes [14].
The present study was designed to verify if, in on-line
mixed hemodiafiltration, a greater solute removal than
in posthemodiafiltration may be obtained by further in-
creasing the total infusion rate (QS) and forcing the QUF
to achieve the most efficient convective transport. The
present level of technology of hemodiafiltration ma-
chines does not help to automatically plan a session, in
order to accomplish this task safely and easily, nor does
it allow the precise calculation of the infusion volume
best able to maximize solute removal by convection.
Consequently, in this study we developed and applied a
new feedback system which was able to automatically
maintain TMP within the highest range of safety during
the session, while at the same time ensuring a constant
QUF and the highest possible filtration fraction (FF) by
optimizing the ratio between prefilter and postfilter infu-
sion.
METHODS
Twenty uremic patients (7 female and 13 male, aged
63  17 years), who were on three times weekly renal
replacement therapy for 9.7 7.2 years (9 with standard
hemodialysis, 11 with posthemodiafiltration or mixed
hemodiafiltration), gave their informed consent to the
study. The mean body weight was 60.3  12.8 kg, and
the mean urea distribution volume (Vu), kinetically esti-
mated, was 32.7  6.3 L. All the patients underwent a
randomized sequence of five procedures (the midweek
session of five consecutive weeks): one session of standard
Fig. 1. Schematic representation of the on-line system for mixed hemo-
diafiltration with the transmembrane pressure (TMP) feedback control
device. Substitution fluid is diverted from the dialysate circuit (D) by
a peristaltic pump (IP1) placed on the common Y branch of the infusion
path (S). This divides the solution to the prefilter (QSpre-D) and postfilter
(QSpost-D) infusion site. The rate of postdilution infusion is controlled by
an additional pump (IP2). Four pressure transducers (P), placed at the
inlet and outlet blood and dialysate ports of the filter (F), record and
send continuous signals (dotted lines) to a personal computer (PC).
The efferent signals (arrow) from the PC regulate the speed of IP2 in
mixed hemodiafiltration. The system also works in posthemodiafiltra-
tion, where the Y branch of the infusion line connected to the prefilter
site is clamped. More detailed explanations are in the text. UF1 and
UF2 are the ultrafilters placed on the dialysate and substituate lines,
respectively.
hemodialysis (procedure A), one of on-line postdilution
hemodiafiltration (procedure B), and three sessions of on-
line mixed pre- and postdilution hemodiafiltration with
variable substitution fluid volume (procedures C, D, and
E). The dialyzers used were a low-flux 1.8 m2, and a
high-flux 2.1 m2 polysulfone membrane (F8 HPS and
HDF 100s) (Fresenius, FMC, Bad Homburg, Germany).
The length of the session (time, 227  18 minutes) and
blood flow (QB), 403  57 mL/min, were set as constant
for each patient for each session in the study. Dialysate
flow (QD) was 500 mL/min in hemodialysis. In hemodia-
filtration, the effective QD entering the dialyzer compart-
ment resulted after subtraction of the amount diverted
for infusion from the set value of 800 mL/min.
The TMP feedback control
On-line mixed hemodiafiltration was performed with
a 4008 H on-line Fresenius system modified with the
application of a Y-shaped infusion line and an additional
peristaltic pump on one Y branch, which diverted part
of the total infusion directed to the postfilter port to
the prefilter infusion site, as detailed elsewhere [14] and
schematically shown in Figure 1. Inlet and outlet blood
and dialysate pressures were continuously recorded by
means of four pressure transducers connected to an ex-
ternal computer and the mean pressure gradient between
blood and dialysate compartments along the dialyzer
fibers (TMPm, mm Hg) was calculated instantaneously
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using the following equation:
TMPm  0.5 * [(PBin  PBout) 
(PDin  PDout)]  o (Eq. 1)
where o (mm Hg), the mean oncotic pressure exerted
by the plasma proteins, was calculated with the Van’t
Hoff equation.
Six hundred TMPm values were recorded per minute
and were filtered, buffered, and averaged for each min-
ute. Inlet plasma water flow rate (QPWin) (mL/min) was
calculated on-line from the effective blood flow (QBe 
QB compensated by means of the arterial pressure), from
hematocrit, which was monitored on-line with an inte-
grated device (Blood Volume Monitor, Fresenius, FMC,
Bad Homburg, Germany) and from a default value for
total protein concentration [23]. The FF (i.e., the fraction
of QPWin ultrafiltered during the passage through the dia-
lyzer) was defined, in analogy with a more strict defini-
tion [24], as:
FF  (1 QPWout/QPWin)  QUF/QPWin (Eq. 2)
where QPWout equals the outlet plasma water flow rate
(mL/min).
The total infusion rate in posthemodiafiltration (treat-
ment B) was set by the device in order to obtain an
initial FF of 0.5 (i.e., QUF  0.5 * QPWin). Because one of
the purposes of the study was the assessment of the
optimal amount of total infusion in mixed hemodiafiltra-
tion, three different QS were planned for the three experi-
mental sessions on an individual basis: QS  0.75 · QPWin
(treatment C), QSQPWin (treatment D), and QS 1.25 *
QPWin (treatment E). QS was split into pre- and postinfusion
(QSpre-D, QSpost-D) at relative infusion rates allowing a ratio
QSpost-D/QPWin of 0.5 to be obtained.
Subsequently, the system self-regulated the ratio of
pre- to postinfusion in order to maintain the TMPm
within its established safe range of variation (250 to 300
mm Hg), without affecting the total QS, nor the planned
QUF. If TMPm fell below the lowest value of the range,
a small amount of fluid (5 to 10 mL/min) was diverted
from pre- to postinfusion at intervals of 2 minutes by in-
creasing the postinfusion pump speed, increasing FF (and
thus TMPm) as a result. Vice versa, the same amount of
fluid was diverted from post- to predilution, thus reduc-
ing FF, whenever TMPm rose beyond its maximum toler-
ated value. In short, the feedback was aimed at ensuring
throughout the sessions the highest FF compatible with
the progressive hemoconcentration and loss of hydraulic
membrane permeability. The TMP feedback control also
worked effectively in posthemodiafiltration, during which
the infusion pump speed was increased or decreased by
signals generated from the TMPm reading.
Values for the in vivo dialyzer ultrafiltration coeffi-
cient (KUFD), calculated on-line as the ratio QUF/TMPm,
were used as a proxy to evaluate instantaneous changes
in the hydraulic permeability of the dialyzer during the
sessions.
Solute removal
Blood samples were drawn from the arterial port at
the start and at the end (slow-flux technique) of each
experimental session and plasma concentrations (Ci, Cf)
were measured for urea (60 D), creatinine (113 D), and
phosphate (96 D) as markers of the low-molecular-
weight toxins, and for 2-m (11.8 kD) as a medium-high-
molecular toxin. The effluent dialysate was collected with
a proportional pump connected to the outlet line and
withdrawing fluid at a constant rate over the session.
The mass of solutes removed (MTDQ) during each session
was calculated from the effluent dialysate sample (50
mL), representative of the whole spent dialysate. Total
2-m removal was also calculated using the mass balance
from the blood side (MTB), being the difference of the
products of initial and final extracellular volume (Vex)
and C, assuming a value for the final Vex equal to one
third of the Vu. Albumin removed by convection was
measured by colorimetry in the spent dialysate. The
mean efficiency of each session was evaluated by calcu-
lating the mean dialysate clearances of the session (KDQ)
for urea, creatinine, phosphate, and 2-m with a modified
equation of the direct quantification method (DQ) [25]:
KDQ  [MTDQ  ln (Cf/Ci )]/[t  (Cf  Ci)] (Eq. 3)
Calculated as above, KDQ underestimates the actual dia-
lyzer clearance [26]. However, this error is systematic
and constant and it is unlikely to affect the results of a
comparison between the different procedures in the same
patient. Single-pool Kt/V (spKt/V) and equilibrated Kt/V
(eKt/V) for urea were estimated with the Daugirdas
equations [27].
Statistical analysis
The descriptive analysis was based on the mean 
SD values of continuous normally distributed variables
(concentration, flux, clearance, etc.). The effects of the
procedures on parameters of treatment efficiency (KDQ,
urea Kt/V, MTB, and MTDQ) were tested with the univari-
ate analysis of variance (ANOVA), and the five group
means were compared with the pairwise multiple com-
parison test of Tukey (post hoc test). A probability value
of less than 0.05 was considered significant. Multiple
linear regression (MLR) with several sets of explanatory
variables and nonlinear analysis was used to study the
dependence of KDQ 2-m changes during the procedures
and curve fitting. The value R2 was a measure of goodness
of fit, and the P value of the runs tests was used to elicit
systematic data deviations from the model (significant
deviation if P 	 0.05). The program SPSS for Windows,
Release 11, was used for statistical analysis.
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Table 1. Flow rates (mL/min) during the experimental procedures
Hemodialysis Post-hemodiafiltration Mixed hemodiafiltration
Procedure A Procedure B Procedure C Procedure D Procedure E
(N  20) (N  20) (N  20) (N  20) (N  20)
QPWin Start 22735 23134 23035 22736 22936
End 21032 21231 21233 20935 21035
QSpre-D Start — — 6528 13541 20129
End — — 9841 17457 26060
QSpost-D Start — 14520 12218 11417 10815
End — 12422 9020 7828 4835
FF Start — 0.670.05 0.670.06 0.710.04 0.740.02
End — 0.640.07 0.640.05 0.670.05 0.680.05
Abbreviations are: QPWin, plasma water flowrate in; QSpre-D, prefilter infusion rate; QSpost-D, postfilter infusion rate; FF, filtration fraction. Data are mean  SD.
Values at the start refer to stabilized conditions (see text) achieved about 10 minutes after the start of the sessions. The FF was calculated with equation 2.
RESULTS
The TMP feedback control
The mean plasma water flow (QPW) and infusion rates
(and their changes during the procedures are reported
in Table 1. A total of 30.5  5.6 L per session were
infused in posthemodiafiltration. The total amount of
fluid infused in mixed hemodiafiltration averaged 42.5
8.7 L, 56.8  10.2 L, and 70  11.6 L in sessions C, D,
and E, respectively. In mixed hemodiafiltration proce-
dures, the ratio at which QS was initially split between
pre- and postdilution resulted in TMPm values that were
generally below the lower established limit for the study.
Therefore, the device algorithm caused repeated shifts
of replacement fluid from pre- to postinfusion in steps
of 5 mL every 2 minutes until TMPm stabilized within
the planned range (approximately within the first 10 min-
utes of the procedure). Subsequently, whenever TMPm
rose to its upper level as an effect of the increasing FF,
opposite shifts occurred, diluting the incoming blood and
preserving the planned ultrafiltration. The mean QSpost-D
decreased from a maximum of 65% of the total QS to a
minimum of 48% at the end of session C, from 46% to
31% in session D, and from 35% to 16% in session E.
In posthemodiafiltration (procedure B), the feedback
increased the initial QS until TMPm established within
the planned range, then maintained TMPm stable by
progressively decreasing QS. Figure 2 shows a graphic
representation of one patient file record as an example of
the feedback mechanism. The behavior of the apparent
KUFD, recorded on-line, is shown in Figure 3. This reveals
a significant decrease, which occurred during the post-
hemodiafiltration sessions, mostly in the first half hour
(from 59.1 to 29.7 mL/hour/mm Hg TMP), indicating
a significant deterioration of the hydraulic membrane
permeability due to rapid protein layer formation and
its progressive thickening. On the other hand, predilution
in mixed hemodiafiltration ensured better preservation
of the hydraulic membrane characteristics, as shown by
the higher and stable recorded KUFD values (mean, 57.5
mL/hour/mm Hg). Hemoconcentration with progressive
reduction of QPW was presumably the prevailing factor
inducing increases in TMPm during this procedure.
Efficiency of the procedures
Mean initial and final solute concentrations of the five
procedures are reported in Table 2. The efficiency of the
procedures, as evaluated with urea KDQ and eKt/V, was
significantly higher in on-line hemodiafiltration than in
hemodialysis, irrespective of the infusion mode (Table 3).
Similar results were found for the other tested small sol-
utes, but a statistically significant difference in creatinine
and phosphate KDQ versus hemodialysis (post hoc tests)
was found only in procedures D and B, although limited
to phosphate KDQ in the latter.
Total 2-m removal (Fig. 4), estimated with mass bal-
ance from the blood side, was minimal in hemodialysis,
as expected, and maximal in treatment D (24  20 mg/
session and 293  105 mg/session, respectively). Similar
differences were found in the amount of 2-m recovered
in the total spent dialysate (MTDQ). A difference in re-
moval of about 40 mg/session, clinically relevant but not
statistically significant, was shown between posthemo-
diafiltration and mixed hemodiafiltration (197  62 mg/
session vs. 237 83 mg/session). The difference between
MTB and MTDQ arises mostly from the use of nonequili-
brated end-session concentrations in calculations, re-
sulting in an overestimate of MTB, and only in part from
the amount of 2-m absorbed by the membrane during
the procedures, which is negligible with polysulfone
membranes. The post hoc ANOVA tests elicited a sig-
nificant difference in the mean KDQ for 2-m (Fig. 5)
between procedures B and D (posthemodiafiltration,
77.5  11.2 mL/min; mixed hemodiafiltration with QS 
QPW, 90.2 10.9 mL/min, P 0.015), and between proce-
dures D and E (80.9  10.9 mL/min, P  0.039). During
session C, the mean value for 2-m KDQ was lower than
in D but higher than in B (83.9  12.2 mL/min, P NS).
Albumin was not detected in the spent dialysate of
hemodialysis sessions, while a negligible loss (from 4.4
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Fig. 2. Graphic representation of one patient
file record. (A ) Mixed hemodiafiltration. At
the start of the session, small shifts of infusion
fluid from predilution (line b) to postdilution
(line c) increase filtration fraction (FF) and sta-
bilize mean transmembrane pressure (TMPm)
(line a) within its planned operational range
(250 to 300 mm Hg). Subsequently, during the
session, TMPm values exceeding the upper
limit (*) are restored by opposite shifts of infu-
sion fluid. (B ) Posthemodiafiltration. TMPm
control (line a) occurs through changes in the
speed of the pump regulating the total infusion
rate (line c).
to 5.8 g/session) was found during hemodiafiltration ses-
sions, with no significant differences between the infu-
sion modes.
Factors influencing 2-m clearance
Stepwise regression analysis of the pooled data of the
five procedures revealed that among several sets of ex-
planatory variables, QS and QPWin and their interaction
are the best predictors of the maximum 2-m KDQ likely
to be achieved during each session. According to the
statistical model which best fits the experimental data,
a family of quadratic regression curves may be con-
structed to represent the dependence of 2-m KDQ on QS
at a defined value of QPWin (Fig. 6). From the Y intercept
(hemodialysis treatment, absence of infusion), KDQ
curves increase quasilinearly when QS increases up to a
value depending on QPWin. This is observed within the
range of infusion rates applied during postdilution hemo-
diafiltration or during mixed hemodiafiltration when the
amount infused in postdilution is prevailing (session C).
After this point, within the typical range of QS applied
in mixed hemodiafiltration, the increase in KDQ per unit
increase in QS tends to diminish the more fluid is infused
in predilution (decreasing ratio QSpost-D/QS). The regres-
sion curves tend to flatten and KDQ clearances achieve
their maximum (the vertex of the parabola in Fig. 6) at
Fig. 3. Behavior of the apparent ultrafiltration coefficient of the dia-
lyzer [KUF D  QUF/mean transmembrane pressure (TMPm)] as re-
corded on-line during post-hemodiafiltration (lower curve) and mixed
hemodiafiltration (procedure D) (upper curve).
a QS value that is close to the QPWin value (ratio QS/QPWin
1 0.1). From this point on, further increase in QS induces
a significant decline in KDQ, as a result of the combined
negative effect of the excessive shift of infusion to the
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Table 2. Direct quantification: Baseline and end-session solute concentrations
Hemodialysis Post-hemodiafiltration Mixed hemodiafiltration
One-way ANOVA
Procedure A Procedure B Procedure C Procedure D Procedure E (P value)
Urea mmol/L Start 24.46.3 23.65.4 24.17.1 23.46.7 23.46.4 NS
End 5.22.0a 3.91.5 3.91.6 4.01.7 3.91.5 0.047
Creatinine lmol/L Start 769221 778230 787221 769194 795239 NS
End 23980 19562 20362 21271 21279 NS
Phosphate mmol/L Start 1.550.52 1.580.45 1.560.39 1.610.44 1.520.39 NS
End 0.680.19 0.590.13 0.580.13 0.570.16 0.580.16 NS
2-m mg/L Start 24.26.7 23.55.8 24.56.6 25.47.2 24.45.9 NS
End 27.38.0a 4.21.6 3.71.4 3.91.2 4.11.5 0.0001
Data are mean  SD.
a Procedure A vs. procedure B, C, D, and E; post hoc tests (Tukey HSD)
Table 3. Efficiency in small solute removal during the experimental procedures
Hemodialysis Post-hemodiafiltration Mixed hemodiafiltration
One-way ANOVA
Procedure A Procedure B Procedure C Procedure D Procedure E P value
KDQ mL/min
Urea 22219a 25922 26327 26224 25529 	0.0001
Creatinine 18927c 21033 21333 21624 21323 0.021
Phosphate 15428b,c 18233 17531 18438 17329 0.031
Urea eKt/V 1.590.19a 1.860.24 1.890.24 1.840.21 1.840.21 	0.0001
Data are mean  SD; post hoc tests (Tukey HSD).
a Procedure A vs. B, C, D, and E
b Procedure A vs. B
c Procedure A vs. D
Fig. 4. 2-microglobulin (2-m) removal in the four on-line hemodia-
filtration (HDF) procedures, evaluated from the blood side (), and
by direct quantification in dialysate ( ). One-way analysis of variance
(ANOVA); P  NS.
predilution site, which is necessary to keep TMPm under
control, and of a reduction in the 2-m SC, elsewhere
described as occurring at high QUF [28].
DISCUSSION
Postdilution has been commonly held as the most effi-
cient infusion mode in hemodiafiltration. The present
study seems to demonstrate that the limits of this method
may be overcome with a mixed pre- and postfilter infu-
sion mode. On-line mixed hemodiafiltration, applied in
20 patients, yielded a significant increase in 2-m removal
compared to that obtained in posthemodiafiltration. The
premise for these results is that the total infusion was
increased to force convective removal beyond the opera-
tional limits placed in posthemodiafiltration. This in-
creased amount of infusion was added in predilution and
balanced with that in postdilution in order to ensure the
highest possible FF, while simultaneously avoiding ex-
cessive dilution of the inlet solute concentrations and
dangerous hydrostatic pressures within the dialyzer. This
was only feasible by using the feedback device developed
in our unit. Indeed, setting QS and QUF purely on the basis
of the in vitro ultrafiltration coefficient of the dialyzer
may be misleading for several reasons. Basal blood flow,
hematocrit, and protein concentration vary widely be-
tween patients. During the session, hemoconcentration
increases blood viscosity and resistance to flow and pro-
gressive protein concentration contributes to a thicken-
ing of the secondary membrane layer so limiting its hy-
draulic permeability. Proteins exert an increasing oncotic
pressure that resists ultrafiltration [29]. High QUF exacer-
bates this phenomenon by increasing the polarization on
the blood side of the membrane [30], while low QB acts
in the same way, by reducing the shear rate that stirs the
protein layer. Consequently, as the session progresses,
increasingly higher and unpredictable TPM gradients are
often reached in the attempt to maintain the planned
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Fig. 5. Mean dialysate clearances for 2-microglobulin (2-m) of the
five experimental procedures. One-way analysis of variance (ANOVA);
P 	 0.0001. Post hoc tests (significance at P 	 0.05). Treatment effect:
a, hemodialysis (HD) vs. posthemodiafiltration (post-HDF) and mixed
hemodiafiltration; b, mixed hemodiafiltration (treatment D) vs. post-
HDF; c, treatment E vs. treatment D.
QUF in the face of a deterioration in the permeability of
the dialyzer membrane.
Some observations formed the basis of the new feed-
back mechanism developed for the automatic control of
QUF through TMPm. First, at a given blood flow, the
maximal efficiency in convective removal of small- and
medium-molecular weight solutes occurs at the highest
FFs [13, 14]. Second, the highest achievable FF is often un-
predictable, due to the events described above and to an
individual variability, presumably related to the capacity
to recruit fluid from the interstitial space (refilling) as
ultrafiltration progresses. Third, at any given QB, TMPm
is exponentially related to FF, and the slope of the curve
is a function of the hydraulic permeability of the dialyzer
[14]. Fourth, above a certain level of TMPm, the system
becomes unstable and sudden dangerous pressure peaks
are likely to result from small changes in blood flow or
viscosity, venous pressure, or for technical reasons. In a
preliminary experimental setting, similar to that applied
in the study, we observed that peaks frequently occurred
around TMPm values of 350 mm Hg. In such circum-
stances, residual irreversible reduction in the performance
of the dialyzer was observed, even after restoring safer
pressure conditions.
These events are difficult to prevent or counteract by
the ultrafiltration control systems presently implemented
on hemodiafiltration machines, which are of little help
in planning and carrying out a session in which convec-
tion at the maximal FF is sought. An increase in ultrafil-
Fig. 6. Best fitting curves (polynomial 2nd order) relating 2-micro-
globulin (2-m) KDQ with QS at three defined values for QPWin (a, 180
mL/min; b, 220 mL/min; c, 260 mL/min). Analysis was performed on
the pooled data of the five procedures (explanation in the text). The
equation of the model is 2-m KDQ  7.35  0.7 * QS  0.0023 * Q
2
S 
0.000034 * Q
2
S * QPwin; R 2  0.924, P 	 0.0001. Algebraic solution of
the equations for the coordinates of the vertex of each parabola [X
b/2a; Y(b2  4ac)/4a], provided the exact value for QS at which 2-m
KDQ is maximal. a, KDQ 79.7 mL/min at QS  205 mL/min, ratio QS/
QPW  1.1; b, KDQ 87.9 mL/min at QS  230 mL/min, ratio QS/QPW 
1.05; c, KDQ 98.1 mL/min at QS  255 mL/min, ratio QS/QPW  0.98.
tration flux through a high-flux polysulfone membrane
was observed in an experimental setting with intravenous
infusion of hypertonic glucose during postdilution hemo-
diafiltration [31]. In our study this task was efficiently
accomplished automatically and with no technical prob-
lems using the TMP feedback control. In mixed hemo-
diafiltration, the device was able to maintain the TMPm
within its highest safe range by means of small shifts
(5 to 10 mL) of substitution fluid from the postdilution
to the predilution infusion site or vice versa, without
reducing the planned QUF. In posthemodiafiltration, QUF
had to be reset to a lower level as the sessions progressed,
but the FFs that were maintained safely throughout the
treatment were always far beyond the empirical limit of
0.5 taken as a historical reference [32] and yielded a high
removal of 2-m per session. Compared to posthemodia-
filtration, a progressive gain in 2-m clearance was expe-
rienced in mixed hemodiafiltration with increasing infu-
sion rates. The difference in KDQ for 2-m between the two
infusion modes was statistically significant at an infusion
rate close to the QPW of the patient. In mixed hemodiafil-
tration, the characteristics of water and solute transport
of the membrane are better preserved than in postdilu-
tion hemodiafiltration [14], as also demonstrated by the
comparative behavior of the apparent KUFD during the
sessions. Therefore, higher QUF are achievable under safe
operating conditions and eventually result in increased
solute removal.
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The optimal rate of infusion fluid found in this study
(QS  QPWin) is related to the dialyzer employed in the
experimental sessions and was dependent on its hydrau-
lic permeability and size and on its geometric properties
(capillary diameter, arterial blood port, housing, etc.),
all of which determine the internal resistance to flow. It
is likely that other high-flux dialyzers used in hemodiafil-
tration with different geometry and membrane perfor-
mance will show variable, but probably limited, deviation
from this value. However, regardless of the dialyzer char-
acteristics, the TMP-ultrafiltration feedback is able to
establish the optimal ratio between pre- and postdilution
in order to optimize the FF.
The four hemodiafiltration procedures showed a high
degree of efficiency in removing small-size solutes. eKt/V
was significantly higher in hemodiafiltration compared
to hemodialysis sessions. The infusion mode did not ap-
parently influence the results. However, the highest ab-
solute values for creatinine and phosphate KDQ were
observed in session D, in which the highest 2-m removal
was also shown.
The high infusion and QUF were well tolerated by the
patients. Sessions were not complicated by any clinical
incident (infections, hypersensitivity reactions, cardio-
vascular complications). The desired electrolyte and acid-
base balance was easily achieved by small modulations of
the dialysate composition when requested [33, 34]. No
signs of hemolysis were recorded. Loss of albumin was
negligible despite the high QUF, probably because the
careful control conducted by the feedback avoided those
critical TMPm values at which albumin leakage is more
likely to occur. The system operated automatically, with-
out any intervention by the operators after the initial
setting. No technical problems occurred in any experi-
mental session.
CONCLUSION
The mixed infusion mode in hemodiafiltration, con-
trolled by the TMP feedback, seems to improve the depu-
rative capacity of the technique by fully exploiting the
convective mechanism of solute removal. The feedback
allowed the TMP to be set and profiled from parameters
recorded on-line by the machine. It automatically ad-
justed the infusion rate at the maximum FF taking into
account flow conditions, internal pressures, and hydrau-
lic permeability of the dialyzer, and their complex inter-
actions. The high biocompatibility resulting from the use
of synthetic membranes and ultrapure dialysate/substitu-
ate prepared on-line with double ultrafiltration, combined
with the enhanced removal of small- and middle-molecu-
lar uremic toxins, seem to indicate mixed hemodiafiltra-
tion as an effective strategy to prevent or delay the occur-
rence of long-term complications and to promote the
improved survival of dialysis patients.
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